Bone Densitometer Market Growth, Opportunities, and Industry Forecast 2026
The global bone densitometer market is projected to grow at a rate of 4.5% by 2026. Key drivers of this expansion include the rising prevalence of osteoporosis and vitamin D deficiency, a growing geriatric population, technological advancements in bone densitometry, increasing cases of fragility fractures, and a broader surge in bone-related disorders. However, high costs associated with bone densitometer devices may restrain market growth.
Download Sample PDF Copy: https://meditechinsights.com/bone-densitometer-market/request-sample/
Competitive Landscape
Major companies active in the global bone densitometer
market include GE Healthcare, Hologic Inc., Diagnostic Medical Systems
Group, Swissray Global Healthcare Holding Ltd., BeamMed Ltd., Echolight S.p.A.,
Scanflex Healthcare AB, Medonica Co. Ltd., Eurotec Systems S.r.l., Shenzhen
XRAY Electric Co. Ltd., Nanoomtech Co. Ltd., Osteosys Corporation, Trivitron
Healthcare, OsCare Medical Oy, CyberLogic Inc., Pinyuan Medical, AMPall Co.
Ltd., L’accessorio Nucleare S.R.L, BMTech, Demetech AB, Medlink, Osteometer
Meditech Inc., CompuMed Inc., and Lone Oak Medical Technologies LLC, among
others.
A bone densitometer, commonly known as a dual-energy
X-ray absorptiometry (DXA) machine, measures bone mass and mineral content
by assessing how quickly targeted areas of the skeleton absorb ionizing
radiation. It is widely used to diagnose osteoporosis and evaluate an
individual’s risk of osteoporotic fractures. DXA is simple, fast, noninvasive,
and remains the standard method for osteoporosis diagnosis. Bone densitometers
may use ultrasound or X-ray technology to image areas such as the lumbar spine
and hips to detect bone loss.
Growing Adoption of Dual-Energy X-Ray
Absorptiometry (DEXA) Expands Market Demand
DEXA is the preferred technique for diagnosing and
monitoring osteoporosis because it provides accurate, objective measurements of
key bone health parameters. It is also used to assess body composition and
regional fat distribution. Newer applications—including vertebral morphometry,
orthopedic prosthesis evaluation, and monitoring lipodystrophy or lipoatrophy
in HIV-positive patients—have broadened its clinical utility. In addition, DEXA
scanning is relatively inexpensive, offers short scan times, and uses lower
radiation doses than many other imaging modalities. Ongoing technological
advancements in bone densitometers are expected to further increase market
demand.
Rising Focus on Bone Mineral Density
(BMD) Evaluation in Postmenopausal Women Drives Growth
Postmenopausal women are at significantly higher risk
of osteoporosis due to the sharp decline in estrogen levels that accelerates
bone loss. Studies suggest that women may lose up to 10% of their bone mass
during the first five years after menopause. Leading organizations—including
the International Society of Clinical Densitometry, the U.S. Preventive
Services Task Force, and the National Osteoporosis Foundation—recommend routine
BMD testing for women aged 65 and older. BMD assessment is considered the gold
standard for osteoporosis diagnosis and fracture-risk prediction, aided by
tools such as the Fracture Risk Assessment Tool (FRAX). Healthcare providers
may also recommend earlier testing for younger individuals with high-risk
profiles.
Adoption of Quantitative Ultrasound
(QUS) in Children Strengthens Market Expansion
Quantitative ultrasound (QUS) is a newer,
radiation-free, noninvasive method for evaluating bone mineral status in the
peripheral skeleton. Unlike DXA, QUS provides both density and structural
information relevant to fracture risk assessment. It is portable,
cost-effective, and quick to use, making it especially suitable for assessing
bone health in children. These advantages are contributing to increased
adoption of QUS devices.
Download Sample PDF Copy: https://meditechinsights.com/bone-densitometer-market/request-sample/
North America Leads the Global Bone
Densitometer Market
North America holds the largest share of the global
market, supported by a high prevalence of osteoporosis, advanced healthcare
infrastructure, rapid technological innovation, and the presence of major
industry players. Europe and Asia-Pacific follow, with the latter expected to
experience strong future growth driven by rising awareness of osteoporosis,
expanding geriatric populations, growing healthcare spending, and increased
incidence of bone-related disorders.
Strategic Initiatives Strengthen Market
Position
Leading market players are pursuing both organic and
inorganic strategies—including partnerships, acquisitions, collaborations, and
new product launches—to expand their global footprint. Recent examples include:
- February 2022: Echolight Medical and Aurora Spine Corporation
formed a co-marketing partnership combining Echolight’s bone health
technologies with Aurora’s DEXA-based implants.
- July 2021: DMS Imaging extended its manufacturing contract
with FUJIFILM Healthcare Group to cover the ASEAN and MEA regions,
expanding beyond its original European distribution agreement signed in
2017.
- June 2021: Echolight entered the Indian market by securing a
commercial partnership in Chandigarh to distribute its full product line
throughout the country.
- May 2021: Echolight introduced its Radiofrequency
Echographic Multi-Spectrometry (REMS) technology— the first radiation-free
portable bone densitometer—at the Florida Orthopedic Society Annual
Scientific Meeting.
Browse Research Report: https://meditechinsights.com/bone-densitometer-market/
About Medi-Tech Insights;
Medi-Tech Insights is a healthcare-focused business research &
insights firm. Our clients include Fortune 500 companies, blue-chip investors
& hyper-growth start-ups. We have completed 100+ projects in Digital
Health, Healthcare IT, Medical Technology, Medical Devices & Pharma
Services in the areas of market assessments, due diligence, competitive
intelligence, market sizing and forecasting, pricing analysis &
go-to-market strategy. Our methodology includes rigorous secondary research
combined with deep-dive interviews with industry-leading CXO, VPs, and key
demand/supply side decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
Comments
Post a Comment